Related Experiment Videos
Evidence from a nonrandomized study that coronary surgery prolongs survival in patients with two-vessel coronary
Insights
Direct myocardial revascularization surgery improved survival rates for patients with coronary artery disease compared to medical treatment. This benefit was observed in matched pairs and confirmed in a larger registry analysis.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- Coronary artery disease (CAD) management involves surgical revascularization and medical therapy.
- Predictors of survival in CAD patients include ejection fraction, arrhythmias, age, and coronary artery stenosis.
- Optimal treatment strategies require careful comparison of surgical versus medical interventions.
Purpose of the Study:
- To compare the long-term survival rates of surgically treated patients (direct myocardial revascularization) versus medically treated patients with CAD.
- To identify if surgical intervention offers survival benefits in specific CAD subgroups, such as those with two-vessel disease.
Main Methods:
- Matched-pair analysis of 287 surgically treated and medically treated patients from the Seattle Heart Watch arteriography registry.
- Matching criteria included seven key prognostic variables: ejection fraction, ventricular arrhythmia, age, heart murmur, left main coronary artery stenosis (≥50%), number of vessels with stenosis (≥70%), and diuretic use.
- Survival analysis utilized actuarial methods and Cox's proportional hazards model on the matched cohort and the entire registry (n=1524).
Main Results:
- Actuarial survival analysis showed significantly improved survival for the entire surgical matched pair cohort (p=0.008) compared to the medical cohort.
- The surgically treated subgroup with two-vessel disease demonstrated a highly significant survival improvement (p=0.0002).
- Cox's model analysis on the full registry confirmed that surgical therapy significantly predicted improved survival for the overall group (p=0.008) and the two-vessel disease subgroup (p=0.0005).
Conclusions:
- Direct myocardial revascularization surgery is associated with improved survival in carefully selected CAD patients compared to medical management.
- The survival benefit of surgical intervention is particularly pronounced in patients with two-vessel coronary artery disease.
- These findings support the efficacy of surgical revascularization as a treatment modality for specific patient profiles within the Seattle Heart Watch registry.
Abstract:
Within the larger Seattle Heart Watch arteriography registry, surgically treated patients non randomly selected for direct myocardial revascularization were matched to medically treated patients such that each of the 287 pairs was identical in seven variables (ejection fraction, ventricular arrhythmia on resting electrocardiogram, age, heart murmur, stenosis of left main coronary artery greater than or equal to 50%, number of vessels with stenosis greater than or equal to 70%, and use of diuretics) previously demonstrated to be independently predictive of survival. Actuarial survival analyses based on cardiovascular deaths (average follow-up 3.5 years) indicate improved survival for the entire surgical matched pair cohort (p = 0.008) and for the surgically treated subgroup with two-vessel disease (p = 0.0002) when compared to the medical cohort. These results were confirmed by examination of the entire arteriography registry (n = 1524) in which these seven variables were known, using Cox's model for survival analysis. This multivariate, statistical technique indicated that the surgical mode of therapy was significantly predictive of improved survival in surgically treated patients for the entire registry (p = 0.008) and for the subgroup with two-vessel disease (p = 0.0005).